This study used immunodectron microscopic techniques to define the ultrascrud karion ofMAGP1 on the fibrillincontaining midibrils ofthe ocular zonule. A specific anti-MAGP-1 m o n o d o d antibody (MAb), 11B, was produced that did not crossreact with fibrillin-1 or other miaofibrillar proteins. MAb 11B was shown by immunofluorescence to localize i n t d y to zonular tissue. Postembedding immunoelcctrrw micmmpyshowed that MAGPl was d a t e d with mictofibrils throughout the zonule, with the exception of a narrow band of microfibrils at the junction with the lens capsule. With prcembedding labeling, the anti-MAGP1 MAb was found to localize in a aossbanding pattern, at interpals of about 50 nm, to microfibrils throughout the zonule and along bundles of miaofibrils in surrounding
Introduction
Microfibrils, 10-14 nm in diameter, are important structural components of the extracellular matrices of a diverse range of tissues. Viewed by the rotary shadowing technique individual microfibrils have a characteristic beaded filament structure with a periodicity of -50 nm Wallace et al., 1991; Wright and Mayne, 1988) . Morphologically and structurally similar microfibrils are found in association with the elastic protein elastin as constituents of elastic fibers in tissues such as arteries, lung, and elastic ligaments, and as elastin-free bundles in tissues such as kidney, spleen, and the suspensory ligament (ciliary zonule) of the eye. In some tissues, such as skin, elastin-associated and elastin-free microfibrils often occur in close proximity to each other. During Adelaide. Adelaide. South Australia 5005.
vitreous tissue. Rotary shadowing of isolated miaofibrils showed a "beads on a suing'' morphology with a periodicity of about 50 nm. With immunogold labeling, the anti-MAGPl antibody specifically localized on the beads in a symmetrical manner. Oc*lsionally two gold particles were attached to the same bead, suggesting that multiple MAGPl molecules were present in the structure. The results indicate that MAGPl is intimately and regularly associated with the bead regions of fibrillin-containing miaofibrils. The fmdings are consistent with a major structural role for MAGPl in miaofibd biology. (J Histochem Cytochem 4&1389-1397, 19%) KEY WORDS: Microfibril; MAGP; Fibrillin; Eye; Rotary shadowing; Immunoelectron microscopy; Bovine. elastic fiber development, bundles of microfibrils always appear before the elastin core and are considered to act as a scaffold for deposition of the soluble elastin precursor tropoelastin. The microfibrils also have an anchoring function, e.g., linking the elastic fiber to other structural components of the matrix, providing rigid linkage between the ocular lens and the ciliary body, and regulating the growth of long bones, possibly by physical restraint within the periosteum Gibson, 1983,1996; Mecham and Davis, 1994) . The molecular architecture of the microfibrils is still being elucidated and recent evidence indicates that these structures may be heterogeneous in composition. The large (350 KD) rod-like glycoprotein fibrillin-1 is considered the major structural constituent of microfibrils in most instances (Corson et al., 1993; Pereira et al., 1993; Sakai et al., 1986 Sakai et al., , 1991 Maddox et al., 1989) . However, recent evidence indicates that a closely related molecule, fibrillin-2, is the major component of microfibrils in cartilaginous tissues and that fibrillin-2 is also expressed for a limited period during embryogenesis in other tissues (Zhang et al. ,1995 Mariencheck et al. 1994) . In many tissues, it is believed that fibrillin-2 is incorporated into microfibrils principally involved in the early stages of elastic fiber formation (Zhang et al., 1995) . It is not yet clear if the two forms of fibrillin exclusively form distinct microfibrils or if they can coexist in the same microfibril. The genes for fibrillin-1 and fibrillin-2 have been linked respectively to the related congenital disorders Marfan syndrome and congenital contractual arachnodactyly (Maslen and Glanville, 1993; Ramirez et al., 1993; Dietz et al., 1991; Lee et al., 1991) . Skin fibroblasts cultured from a number of Marfan syndrome patients synthesize abnormal fibrillin molecules and lay dawn microfibrils with deranged morphologies (Kielty and Shuttleworth, 1994; Milewicz et al., 1992) . Marfan syndrome patients often exhibit severe cardiovascular, skeletal and ocular abnormalities which illustrates the importance of fibrillin-containing microfibrils for the structural integrity of these tissues.
A number of additional proteins have been identified with the microfibrils in developing tissues. These include MAGPs 1 and 2 (Gibson et al., 1986 (Gibson et al., ,1991 , MFAPs 1, 3, and 4 (Abrams et al., 1995; Zhao et al., 1995; Yeh et al., 1994) , the fibrillin-like protein named LTBP-2 (Gibson et al., 1995) , fibulin-1 (Roark et al., 1995) , and MP78/70 (pig-H3) . The best characterized of these is MAGP-1, a 31-KD acidic, elastin-binding glycoprotein that co-distributes with microfibrils in most if not all tissues where they occur, including the tissues mentioned above (Brown-Augsburger et al., 1994; Kumaratilake et al., 1989; Gibson and Cleary, 1987) . MAGP-1 appears to be covalently bound to the microfibrils by disulfide linkages (Gibson et al., 1986 .
Here we present evidence that MAGP-1 is associated with zonular microfibrils at regular periodic intervals of about 50 nm and that this periodic labeling corresponds to the beads of the beaded filament structure revealed by the rotary shadowing technique. Therefore, it is evident that MAGP-1 is a constituent of or is uniformly attached to these beads, and that the glycoprotein is likely to be important for functional integrity of the microfibrils.
Materials and Methods
Mondonal Antibody Production. MAbs were produced by standard techniques (Harlow and Lane, 1988) in hybridoma cultures derived from X-63 myeloma cells and lymph node cells from Balbk mice immunized with purified, reduced, and alkylated MAGP prepared from fetal bovine nuchal ligament . MAbs were selected for their ability to react specifically with MAGP-1 on enzyme-linked immunosorbent assay (ELISA) and immunoblots and to localize strongly by immunofluorescence on elastic fibers in sections of nuchal ligament. The methods used for the above procedures have been described previously Cleary, 1985,1987) . Selected hybridomas were injected into the peritoneum of pristane-primed mice for the production of ascites fluid. Anti-fibrillin-1 MAb A5 has been described previously (Gibson et al., 1995) .
Immunolabeling of Embedded Tissue. Eyes from adult cows were obtained from the slaughterhouse within 10 min of death and cooled on ice. The ocular zonule was dissected with portions of the lens capsule and ciliary processes attached. This tissue was fixed in PBS, pH 7.2, containing sucrose 4%, paraformaldehyde 4%. and glutaraldehyde 0.25%. then processed by the progressive lowering of temperature technique into Lowicryl HMzo resin (Voorhout et al., 1991) using a Reichert AFS automatic freezesubstitution unit (Leica; Vienna, Austria) and polymerized at -30'C for 48 hr under w light.
Sections approximately 70-80 pm thick were cut and incubated with 0.02 M glycine for 30 min to block free aldehyde groups, blocked further with 1% ovalbumin in PBS for 20 min, and incubated at 4'C for 18 hr with monoclonal anti-MAGP-1 antibody 11B (ascites) diluted 1:200 with PBS. The sections were again treated with ovalbumin (six times for 5 min) and incubated for 1 hr with goat anti-mouse IgG+IgM antibodies conjugated to 10-nm gold particles (Amersham; Amenham, UK) diluted 1:30 in PBS. The sections were extensively washed with ovalbumin (six times for 5 min), followed by deionized water (four times for 5 min), and were stained with aqueous uranyl acetate and lead citrate for examination at 100 kV in a Philips CMlOO transmission electron microscope.
Controls consisted of sections which were incubated with PBS or with ascites containing an MAb to the parasite Giardia lamblia (a kind gift from Dr. G. Mayrhofer, Department of Microbiology and Immunology, University of Adelaide) in place of the anti-MAGP-1 primary MAb.
Immunolabeling of Tissue Before Embedding. Freshly dissected zonule with attached portions ofthe lens capsule and ciliary body was incubated for 18 hr with an equal volume of 0.2 M ammonium bicarbonate buffer, pH 7.4, containing monoclonal anti-MAGP-1 antibody 11B (ascites, diluted 1:lO). The tissue was washed with the bicarbonate buffer (four times for 15 min). In initial experiments the tissue was then incubated for 8 hr with the anti-mouse Ig-gold conjugate (described above) diluted 1:30 in 20 mM Tris-HC1 buffer, pH 8.0, containing 0.13 M NaCI, 20 mM sodium azide, and bovine serum albumin (1 mglml). However, in later experiments this step was omitted so that the antibody labeling periodicity could be more clearly discerned. The tissue was then rinsed with bicarbonate buffer (four times for 15 min). The above procedures were all performed at 4°C. The tissue was fived with paraformaldehyde and glutaraldehyde, then postfixed in osmium tetroxide, dehydrated, and embedded in Spurr's epoxy resin. Sections were then cut, stained and examined as described above. For controls, the tissue was incubated either with PBS or with anti-Giardzu antibody in place of the anti-MAGP-1 MAb.
Rotary Shadowing and Immunolabeling. Immunostaining and subsequent rotary shadowing were conducted by a method based on that of Wallace et al. (1991) . The ciliary zonules were dissected from three adult bovine eyes, freshly obtained from the slaughterhouse. Care was taken to remove the lens capsule and the ciliary body. The zonule tissue was washed with PBS, pH 7.4, containing the proteinase inhibitors phenylmethylsulfonyl fluoride (1 mM) and N-ethylmaleimide (5 mM) and EDTA (2.5 mM), followed by several changes of distilled water. The tissue was then gently homogenized with five strokes in a glass-teflon homogenizer containing an equal volume of 0.2 M ammonium bicarbonate, pH 7.4. The homogenate was divided into several aliquots. One aliquot was incubated for 18 hr at 4'C with anti-MAGP-1 MAb 11B at a final dilution of 1:lOO. Another aliquot was incubated without primary antibody as a control. Zonular material was then pelleted by centrifugation at 15.000 x g for 15 min and rinsed with two changes of bicarbonate buffer. The pellet was resuspended in the same buffer containing a 1:lO dilution of the anti-mouse IgG+IgM antibody-10-nm gold conjugate and incubated for 3 hr at room temperature, then for 18 hr at 4'C. Zonular material was again washed by centrifugation and resuspension as described above. After the final resuspension, the homogenate was mixed with an equal volume of glycerol and sprayed on freshly cleaved mica discs (Tyler and Branton, 1980) . Rotary shadowing using a Cressington CFE50 Freeze Etch Unit was conducted exactly as described by Wallace et al. (1991) . except that an angle of 7" was used for platinum. Replica thickness was determined as 1.7 nm for platinum and 19 nm for carbon. The replicas were transferred to copper grids and examined by transmission electron microscopy as described above.
Zonular homogenate were also reacted with rabbit polyclonal antibodies to bovine MAGP-2 and bovine Type 1 collagen at a dilution of 1:50. In these instances goat anti-rabbit IgG antibody conjugated to 10 nm gold (Amersham) was used as the secondary antibody.
A Figure 1 . lmmunobld analysis of anti-MAGP-1 MAb 116. A microfibrillar protein preparation was made by treating fetal nuchal ligament with Saline-dithiothreitol after exhaustive extraction with 6 M guanidinium chloride. The major proteins were purified as described previously 
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Results
S'eczFcity of Anti-MAGPI Monoclonal Antibody
MAb 11B was selected for the study on the bases of antigen specificity and strong localization to zonular fibers. With the ELISA technique, ascites containing this antibody registered a titer in excess of 1:64,000 vs MAGP-1 but showed no titer to other microfibrilassociated proteins fibrillin-1, MAGP-2, or MP78/70 (Pig-H3). MAb 11B strongly reacted only with bands corresponding to MAGP-1 monomer, dimer, and high molecular weight aggregates when immunoblotted against 6 M guanidine-dithiothreitol extracts and saline-dithiothreitol extracts of nuchal ligament tissue (not shown). Immunoblotting of the antibody against purified microfibrilassociated proteins is shown in Figure 1 . MAb llB showed a strong reaction vs MAGP-I ( Figure 1B , Lane 3) but no reaction with similar amounts of fibrillin-1, MP78/70 or MAGP-2 (Figure lB, Lanes 1, 2. and 4, respectively). The successful transfer of the 340 KD fibrillin-1 band from the gel to the membrane was certified by staining a duplicate blot with anti-fibrillin-1 MAb AS ( Figure IC) . Using immunofluorescence on fresh frozen unfixed tissues from 230-day fetal calves, MAb 11B showed a similar tissue staining pattern to that previously described with a polyclonal antibody to MAGP-1 (Gibson and Cleary, 1987) . MAb 11B localized to elastic fibers in tissues such as ligament, aorta, lung, and skin, and to reticular networks corresponding to microfibrillar bundles in nonelastic tissues (not shown). Of particular relevance to this study, strong localization to the ciliary zonule was observed ( Figure 2) . Note that the outer region of the lens capsule is surrounded by a thin layer of zonular material that also stains intensely.
Postembedding Labeling of the Ciliary Zonule
With a standard postembedding-labeling technique, anti-MAGP-B C 1 2 3 4 1 2 3 4 1 MAb 11B labeled the zonule microfibrils ( Figure 3A ) extensively and intensely. No order could be discerned in the staining pattern of the antibody as visualized by the immunogold particles. The finding was expected with this technique, because most of the MAGP-I epitopes remain buried in the resin during the immunolabeling process. Very few gold particles were observed in control sections incubated without primary antibody (not shown) or with anti-Giardia MAb instead of anti-MAGP-1 MAb ( Figure 3B) . Interestingly, the anti-MAGP-1 immunolabeling was uniform throughout the zonule, with the exception of the layer surround- ing the lens capsule ( Figure 3C ). In this region the zonule microfibrils lie parallel to the surface of the lens capsule. Most of these microfibrils labeled strongly with the anti-MAGP-1 MAb. However, morphologically identical microfibrils in a narrow layer about 400 nm thick at the junction between the lens capsule and the zonule stained poorly with the antibody.
Preembedding Labeling of Zonule and Vitreous
Incubation of ciliary zonule with anti-MAGP-1 MAb 11B before fixation and embedding resulted in strong periodic labeling of the microfibrils throughout the tissue ( Figure 4A ). This labeling was visualized as a crossbanding pattern that was perpendicular to the microfibrils. The staining was so distinct that it could be visualized without addition of the secondary antibody-gold conjugate. The periodicity of label varied across the section, from 45 to 55 nm. In tissue incubated without antibody, the appearance of the microfibrils was similar to that visualized in freshly fixed and embedded tissue (not shown). Similarly, no crossbanding of the microfibrils was observed when tissue was incubated with anti-Grind12 MAb instead of anti-MAGP-1 MAb ( Figure 4B ). Small bundles of similar microfibrils were observed in vitreous tissue attached to the zonule. These microfibrils also stained in a periodic manner, at an interval of about 48 nm, with the anti-MAGP-1 MAb ( Figure 4C ). No labeling of the fine collagen fibrils, which surround the microfibrils in this tissue, was detected. These findings indicate that MAGP-1 is present at regular intervals along the microfibrils.
Rotary Shadowing of Immunofabeled Microfibrils
Rotary shadowing of isolated microfibrils from the zonule revealed their characteristic substructure, which resembles a string of beads ( Figure 5 ). In individual microfibrils the distance from the center of one bead and the next varied, but in general the period was between 49 nm and 55 nm. The variation was due to differences in the length of the inter-bead regions, since the beads had a relatively constant diameter of about 21 nm.
To determine which region of the microfibril is associated with MAGP-1, microfibrils were labeled with anti-MAGP-l MAb and immunogold conjugate before shadowing ( Figures 5A-5C ). The immunogold particles appeared as spheres about 25 nm in diameter, with intense black centers. Many immunogold particles were observed in attachment to the bead regions of the microfibrils ( Figures  5A and 5B) . Overall, from the several fields examined, the labeling dficiency of the beads with an immunogold particle was estimated to be about 5%. Occasionally an immunogold particle appeared to be displaced slightly to either side of a bead, but none was observed in association with the inter-bead region. These findings suggest that MAGP-1 is exclusively associated with the bead regions. Interestingly, in some instances (about 0.2% of the total number of beads observed), a single bead was labeled with two A.B x 57,500; C x 26.500. Bars: A,B = 0.2 immunogold particles ( Figure 5C ). indicating that the reactive MAGP-1 epitope occurred more than once on each bead. This suggests that multiple MAGP-1 molecules are associated with each of these structures. Immunogold particles were not found in association with the microfibrils in control preparations incubated without primary antibody (not shown), with anti-Type 1 collagen antibodies (not shown), or with anti-MAGP-2 antibodies ( Figure 5D ).
Discussion
Despite extensive research, the precise molecular composition and organization of fibrillin-containing microfibrils.,are still uncertain. Electron microscopic techniques have been used by several groups to study the ultrastructure of these microfibrils and to attempt to elucidate the organization of fibrillin-1 within these structures Sakai et al.. 1991; Wallace et al.. 1991; Wright and Mayne, 1988 ). The microfibrils have been shown, by techniques of negative staining and rotary shadowing to have a beaded filament structure with a periodicity of about 50 nm between the center of each bead Wallace et al., 1991) . Keene et al. (1991) . using a preembedding labeling technique, showed that an MAb to fibrillin-1 localized in a periodic manner to the microfibrils in homogenates of nuchal ligament, skin, and amnion. In nonstretched tissue the interval of labeling was measured at 50 nm, whereas in stretched tissue the periodicity was substantially increased to W30 nm. This indicated that the microfibrils were somewhat compliant under tension. Visualized by negative staining, the anti-fibrillin-1 MAb was consistently found to bind to the interbead regions of the microfibrils close to one side of the beads, indicating that the beads were asymmetric. Wallace et al. (1991) , using immunolabeling in combination with the rotary shadowing technique, showed that an MAb to fibrillin-1 localized to morphologically identical microfibrils that compose the ocular zonule, again at the junction between the beads and the inter-bead regions. The above observations were extended by Sakai et al. (1991) . who showed that when microfibril preparations were treated with two MAbs for different regions [PFl and PF3 (Maddox et al., 1989) ] of the fibrillin-1 molecule, two bands (14-18 nm apart) with the same 50nm period were observed. This and other observations led the authors to suggest that fibrillin molecules are arranged within the microfibril as bundles of six to eight molecules in a parallel head to tail alignment. Handford et al. (1995) have proposed an alternative model for the microfibril, with fibrillin molecules aligned in an antiparallel manner. This model is based on the crystal packing of isolated calcium-binding EGFlike domains that comprise most of the fibrillin molecule. However, it is not consistent with the antibody labeling periodicity observed for fibrillin monoclonal antibodies described above Sakai et al., 1991; Wallace et al., 1991) .
Current evidence suggests that bundles of fibrillin molecules comprise the inter-bead regions of the microfibrils. However, the nature of the bead regions is less clear. It has been proposed that the beads may represent overlapping or interacting ends of fibrillin molecules, perhaps in association with other proteins . Because the monomeric form of fibrillin-1 is a flexible rod -148 nm long , which is more than twice the length of the labeling periodicity for anti-fibrillin-1 antibody, there must be extensive overlap and/or folding of fibrillin molecules within the microfibrils. The organization of tfibrillin-2containing microfibrils is also not known but it is assumed that fibrillin-2 will be aligned in a similar manner to fibrillin-1 because of the close structural resemblance between the two molecules. It has been proposed that fibrillin-2-containing microfibrils may be more flexible than microfibrils containing only fibrillin-1 .
MAGP-1 is a 31-KD glycoprotein that is associated with most fibrillin-containing microfibrils Gibson and Cleary, 1987; Gibson et al., 1986) . MAGP-1 has a twodomain structure consisting of an extended amino terminal domain, rich in proline, glutamine, and acidic amino acids, and a carboxyl terminal domain which contains all 13 of the cysteine residues, indicating that it is likely to be extensively folded (Gibson et al., 1991) . MAGP-1 can be solubilized from elastic tissues (with fibrillin-1) only in the presence of reducing agents, suggesting that MAGP-1 is disulfide-bonded to the microfibrils (Gibson et al., 1986) . MAGP-1 has been shown to bind in vitro to the elastin precursor tropoelastin, and to act as a substrate for the crosslinking enzyme transglutaminase (Brown-Augsburger et al., 1994) . It has been proposed that MAGP-1 may mediate the binding and alignment of tropoelastin to the microfibrils during elastic fiber formation (Gibson et al., 1991) .
In this study we have used an MAb, together with several immunoelectron microscopic techniques, to confirm that MAGP-1 is intimately associated with the microfibrils and to determine the ultrastructural location ofthe protein on these structures. An MAb to MAGP-1 was produced to avoid possible crossreactivity problems encountered with a previously described polyclonal anti-MAGP-1 antibody . MAb 11B showed no crossreactivity with fibrillin-1 or other microfibril-associated proteins by immunoblotting ( Figure 1) . However, the immunofluorescence staining pattern of MAb 11B was identical to that of the polyclonal anti-MAGP-1 antibody in a range of tissues, including the ciliary zonule ( Figure 2 ). Conventional immunoelectron microscopy confkmcd that MAb 11B localized strongly to the fibrillin-containing microfibrils throughout this tissue, with the exception of motphologically identical microfibrils at the junction of the zonule and the lens capsule (Figure 3) . This finding indicates that although MAGP-1 is associated with most fibrillin-containing microfibrils, there may be specialized circumstances where microfibrils lack MAGP-1. This possibility is supported by the work of Davis (1994) , who showed that in developing mouse aorta the fibrillin-containing microfibrils that connect endothelial cells to the elastic lamina were not immunoreactive to MAGP-1.
A preembedding labeling technique was used to show that the anti-MAGP MAb localized strongly along the zonular microfibrils at periodic intervals of about 50 nm (Figure 4) . which is the same periodicity found for MAbs to fibrillin-1 Wallace et al., 1991) . This indicated that MAGP-l is associated regularly and specifically within each repeat unit of the zonular microfibrils. In addition, small bundles of similar microfibrils within the surrounding vitreous also specifically stained with the antibody in the same periodic manner. This confirmed that the staining pattern was not confined to the zonule. Microfibrils with the morphological characteristics of fibrillin-containing microfibrils have previously been described in the vitreous (Wallace et al., 1991; Wright and Mayne, 1988) . Rotary shadowing of zonular microfibrils yielded the same beaded filament morphology described by others Wallace et al., 1991; Wright and Mayne, 1988) . The periodicity (about 50 nm) and the calculated sizes of the beads (21 nm) and the inter-bead domains (28-34 nm) were consistent with those found in these other studies. Immunogold labeling with anti MAGP-1 MAb 11B showed widespread, specific symmetrical localization to the beads, with no label on the inter-bead regions, indicating that MAGP-1 was specifically associated with the beads (Figure 5A-5C ). Interestingly, antibodies to a closely related microfibril-associated protein, MAGP-2, showed no localization to zonule microfibrils ( Figure 5D ). This is consistent with immunolocalization studies showing that MAGP-2, which has a much more restricted tissue distribution than MAGP-1, is not present in adult zonule (M.A. Gibson, J.S. Kumaratilake, and E.G. Cleary, manuscript in preparation) . It is possible that MAGP-2 is associated specifically with fibrillin-kontaining microfibrils rather than with those containing only fibrillin-1.
Overall, the present study indicates that multiple MAGP-1 molecules are located on each bead within the microfibrils, inferring that their presence is important for the full functional integrity of these structures. Certainly it is evident that MAGP-1 plays some role that is independent of its elastin-binding capabilities, since elastin is not present in tissues such as zonule. The findings support our previous suggestion that MAGP-1 may stabilize, by disulfide bonding, the head-to-tail interaction of fibrillin-1 molecules within the bead regions . In addition, because the antibody labeling indicates that MAGP-1 is not deeply buried within the beads, it is possible that MAGP-1 is involved in lateral interactions between microfibrils. Such interactions could be between MAGP-l molecules on adjacent microfibrils, since MAGP-1 readily self-aggregates (Brown-Augsburger et al., 1994) . Possible models of microfibril structure are shown in Figure 6 . In both models, MAGPI is shown on the surface of the beads, where it can possibly interact internally with the ends of fibrillin molecules and externally with the beads of other microfibrils and with tropoelastin during elastinogenesis. Figure 6A is based on the model proposed by Sakai et al. (1991) and shows fibrillin molecules arranged in nonstaggered parallel aggregates between the beads, and incorporates the idea that the beads are regions of end-to-end interaction between fibrillin molecules. In this model the fibrillin monomers must be extensively folded from 148 nm to around 50 nm in length. An alternative model, shown in Figure 6B , is also consistent with the antibody labeling data but allows much less folding (up to 30%) of the fibrillin-1 molecule. In the latter model, bundles of three or four fibrillin molecules span three beads but overlap by around 50% with successive bundles in a parallel manner along the microfibril. Obviously, the determination of specific intermolecular interactions between the miciofibrillar constituents will be necessary before the precise architecture of the fibrillincontaining microfibrils can be elucidated.
